SEP 10, 2026 · PHASE 3 TRIAL
A Study Comparing BL-B01D1 in Combination With Osimertinib Versus Osimertinib Alone in Patients With Locally Advanced, Unresectable EGFR-mutated Non-small Cell Lung Cancer(Stage III) Whose Disease Has Not Progressed Following Definitive Platinum-based Chemoradiation Therapy(PANKU-Lung08)
ClinicalTrials.gov
This is a clinical trial registry record describing a planned Phase 3 study with no results reported; the trial is actively recruiting and outcome data are not yet available.
Reported
Planned enrollment418
PhasePHASE 3
Primary outcome measureProgression-free survival (PFS)